| Characteristics . | Values . | . |
|---|---|---|
| . | Missing data (%) . | |
| Sociodemographiccharacteristics | ||
| Age (years), mean (SD) | 67 (13) | – |
| Men, % | 65 | – |
| Education (years), % | 1.2 | |
| ≥12 | 36 | |
| 9–11 | 49 | – |
| <9 | 15 | – |
| Low health literacya, % | 19 | – |
| Kidney disease | ||
| Duration of nephrology care before inclusion (years), median (IQR) | 4.3 (2.0–8.2) | 4.7 |
| Primary kidney disease, % | 6.0 | |
| Glomerulonephritis | 19 | – |
| Diabetic nephropathy | 21 | – |
| Hypertensive nephropathy | 22 | – |
| Vascular nephropathy | 8 | – |
| Tubulointerstitial nephritis | 13 | – |
| Polycystic kidney disease | 6 | – |
| Other or unknown | 11 | – |
| eGFR (mL/min/1.73 m2), median (IQR) | 32 (23–41) | – |
| CKD stage at entry, n (%) | – | |
| Stages 2 and 3 | 1670 (55) | – |
| Stage 4 | 1240 (41) | – |
| Stage 5 | 123 (4) | – |
| Albuminuria category, % | 9.1 | |
| Normal | 28 | – |
| Moderately increased | 31 | – |
| Severely increased | 41 | – |
| Comorbidities and medications | – | |
| BMI (kg/m2), mean (SD) | 29 (5.8) | 2.1 |
| Hypertension, % | 91 | – |
| Diabetes, % | 43 | – |
| Heart failure, % | 13 | – |
| Cardiovascular disease (excluding heart failure), % | 52 | 1.4 |
| Hyperpolypharmacy (≥10 drug classes per day), % | 43 | – |
| Characteristics . | Values . | . |
|---|---|---|
| . | Missing data (%) . | |
| Sociodemographiccharacteristics | ||
| Age (years), mean (SD) | 67 (13) | – |
| Men, % | 65 | – |
| Education (years), % | 1.2 | |
| ≥12 | 36 | |
| 9–11 | 49 | – |
| <9 | 15 | – |
| Low health literacya, % | 19 | – |
| Kidney disease | ||
| Duration of nephrology care before inclusion (years), median (IQR) | 4.3 (2.0–8.2) | 4.7 |
| Primary kidney disease, % | 6.0 | |
| Glomerulonephritis | 19 | – |
| Diabetic nephropathy | 21 | – |
| Hypertensive nephropathy | 22 | – |
| Vascular nephropathy | 8 | – |
| Tubulointerstitial nephritis | 13 | – |
| Polycystic kidney disease | 6 | – |
| Other or unknown | 11 | – |
| eGFR (mL/min/1.73 m2), median (IQR) | 32 (23–41) | – |
| CKD stage at entry, n (%) | – | |
| Stages 2 and 3 | 1670 (55) | – |
| Stage 4 | 1240 (41) | – |
| Stage 5 | 123 (4) | – |
| Albuminuria category, % | 9.1 | |
| Normal | 28 | – |
| Moderately increased | 31 | – |
| Severely increased | 41 | – |
| Comorbidities and medications | – | |
| BMI (kg/m2), mean (SD) | 29 (5.8) | 2.1 |
| Hypertension, % | 91 | – |
| Diabetes, % | 43 | – |
| Heart failure, % | 13 | – |
| Cardiovascular disease (excluding heart failure), % | 52 | 1.4 |
| Hyperpolypharmacy (≥10 drug classes per day), % | 43 | – |
aLow health literacy is defined as ‘rarely-often-always needing help to understand written documents from the doctor or the pharmacist’.
| Characteristics . | Values . | . |
|---|---|---|
| . | Missing data (%) . | |
| Sociodemographiccharacteristics | ||
| Age (years), mean (SD) | 67 (13) | – |
| Men, % | 65 | – |
| Education (years), % | 1.2 | |
| ≥12 | 36 | |
| 9–11 | 49 | – |
| <9 | 15 | – |
| Low health literacya, % | 19 | – |
| Kidney disease | ||
| Duration of nephrology care before inclusion (years), median (IQR) | 4.3 (2.0–8.2) | 4.7 |
| Primary kidney disease, % | 6.0 | |
| Glomerulonephritis | 19 | – |
| Diabetic nephropathy | 21 | – |
| Hypertensive nephropathy | 22 | – |
| Vascular nephropathy | 8 | – |
| Tubulointerstitial nephritis | 13 | – |
| Polycystic kidney disease | 6 | – |
| Other or unknown | 11 | – |
| eGFR (mL/min/1.73 m2), median (IQR) | 32 (23–41) | – |
| CKD stage at entry, n (%) | – | |
| Stages 2 and 3 | 1670 (55) | – |
| Stage 4 | 1240 (41) | – |
| Stage 5 | 123 (4) | – |
| Albuminuria category, % | 9.1 | |
| Normal | 28 | – |
| Moderately increased | 31 | – |
| Severely increased | 41 | – |
| Comorbidities and medications | – | |
| BMI (kg/m2), mean (SD) | 29 (5.8) | 2.1 |
| Hypertension, % | 91 | – |
| Diabetes, % | 43 | – |
| Heart failure, % | 13 | – |
| Cardiovascular disease (excluding heart failure), % | 52 | 1.4 |
| Hyperpolypharmacy (≥10 drug classes per day), % | 43 | – |
| Characteristics . | Values . | . |
|---|---|---|
| . | Missing data (%) . | |
| Sociodemographiccharacteristics | ||
| Age (years), mean (SD) | 67 (13) | – |
| Men, % | 65 | – |
| Education (years), % | 1.2 | |
| ≥12 | 36 | |
| 9–11 | 49 | – |
| <9 | 15 | – |
| Low health literacya, % | 19 | – |
| Kidney disease | ||
| Duration of nephrology care before inclusion (years), median (IQR) | 4.3 (2.0–8.2) | 4.7 |
| Primary kidney disease, % | 6.0 | |
| Glomerulonephritis | 19 | – |
| Diabetic nephropathy | 21 | – |
| Hypertensive nephropathy | 22 | – |
| Vascular nephropathy | 8 | – |
| Tubulointerstitial nephritis | 13 | – |
| Polycystic kidney disease | 6 | – |
| Other or unknown | 11 | – |
| eGFR (mL/min/1.73 m2), median (IQR) | 32 (23–41) | – |
| CKD stage at entry, n (%) | – | |
| Stages 2 and 3 | 1670 (55) | – |
| Stage 4 | 1240 (41) | – |
| Stage 5 | 123 (4) | – |
| Albuminuria category, % | 9.1 | |
| Normal | 28 | – |
| Moderately increased | 31 | – |
| Severely increased | 41 | – |
| Comorbidities and medications | – | |
| BMI (kg/m2), mean (SD) | 29 (5.8) | 2.1 |
| Hypertension, % | 91 | – |
| Diabetes, % | 43 | – |
| Heart failure, % | 13 | – |
| Cardiovascular disease (excluding heart failure), % | 52 | 1.4 |
| Hyperpolypharmacy (≥10 drug classes per day), % | 43 | – |
aLow health literacy is defined as ‘rarely-often-always needing help to understand written documents from the doctor or the pharmacist’.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
